Reference Data
| Cartalax | 10MG |
|---|---|
| BPC-157 | 5MG |
| TB-500 | 5MG |
| Total Peptide Content | 20MG |
| Formula Type | Multi-peptide research blend |
| Research Focus | Connective tissue biology, extracellular matrix signaling, tissue-response models, angiogenesis-associated pathway research, cellular migration models, and cellular recovery pathways. |
Reference figures are provided for research identification. Always confirm against the batch-specific Certificate of Analysis.
Cartalax Research
Studied in models involving connective tissue biology, cartilage-associated signaling, extracellular matrix pathways, and cellular regulation.
BPC-157 Research
Studied in tissue-response, angiogenesis-associated, gut-barrier, fibroblast activity, cellular recovery, and repair-pathway research models.
TB-500 Research
Studied in models involving actin regulation, cellular migration, tissue-response biology, cytoskeletal signaling, and cellular repair-associated pathway research.
Why Wolverine+ Matters in Research
Wolverine+ is designed around three research peptides with complementary pathway interest. Cartalax is studied in models involving connective tissue signaling, cartilage-associated cellular environments, extracellular matrix regulation, and gene-expression pathway research.
BPC-157 is studied in laboratory models involving tissue-response signaling, angiogenesis-associated mechanisms, gut-barrier biology, fibroblast activity, and cellular recovery pathways. TB-500 is studied in models involving actin regulation, cytoskeletal pathway behavior, cellular migration, tissue-response biology, and repair-associated signaling.
Together, this blend creates a multi-pathway research framework for studying connective tissue support systems, extracellular matrix behavior, cytoskeletal signaling, cellular migration, and tissue-response biology under controlled experimental conditions.
- 10MG Cartalax / 5MG BPC-157 / 5MG TB-500
- 20MG total peptide blend
- Studied in connective tissue and extracellular matrix pathway research
- Relevant to tissue-response, angiogenesis-associated, and cytoskeletal signaling models
- Designed for multi-peptide repair-pathway comparison research
- Third-party testing with internal QA review before release
Why Our Testing Process Is Different
Multi-peptide blends require more oversight than single-compound listings. Disguised Alpha reviews product identity, blend composition, documentation, vial presentation, labeling accuracy, storage expectations, and fulfillment handling before release.
Wolverine+ is reviewed as a specialized peptide blend, not a generic vial. Each batch is evaluated through our internal QA process with attention to analytical documentation, formulation clarity, and direct accountability.
- Third-party analytical verification
- Identity and purity documentation review
- Blend composition and presentation checks
- Internal batch approval before release
- Product labeling and storage expectation review
- Direct oversight from intake to final shipment
Verify Our Claims
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
The Disguised Alpha Standard
Disguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over fulfillment accuracy, packaging quality, storage standards, and customer experience. Our goal is not to be the cheapest research supplier — it is to provide clean, professionally handled compounds with real quality oversight behind them.
Wolverine+ (Cartalax / BPC-157 / TB-500) is sold strictly for laboratory and in-vitro research. It is not for human consumption, veterinary use, or any diagnostic or therapeutic application. Nothing on this page is medical, dosing, or therapeutic advice.